This inventor holds 1 USPTO granted patent. Top assignee: Rutgers, The State University of New Jersey. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Emran O Lallow: Innovator in Cell Transfection Technology
Introduction
Emran O Lallow is a notable inventor based in New Brunswick, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the area of cell transfection. His innovative approach has the potential to enhance the delivery of therapeutic molecules across cell membranes.
Latest Patents
Emran O Lallow holds a patent for a "System and method to use suction to enhance permeabilization and transfection of cells." This patent describes a method and apparatus that promotes the delivery of a molecule across a cell membrane. The technique involves applying suction through a suction tip that creates a seal around the delivery site, thereby enhancing the delivery of the molecule. The controlled application of suction generates a predetermined negative pressure for a specific duration before it is released. This method can significantly improve the uptake and expression of plasmid DNA vaccines, mRNA vaccines, and other nucleic acid molecules introduced subcutaneously. It can also be utilized in conjunction with coated microneedles.
Career Highlights
Emran O Lallow is affiliated with Rutgers, the State University of New Jersey, where he continues to advance his research and innovations. His work is characterized by a commitment to improving medical technologies and therapeutic delivery systems.
Collaborations
Some of his notable coworkers include Jerry W Shan and Jonathan Phillip Singer. Their collaborative efforts contribute to the ongoing research and development in the field of biotechnology.
Conclusion
Emran O Lallow's innovative work in cell transfection technology exemplifies the potential of biotechnology to revolutionize therapeutic delivery methods. His contributions are paving the way for advancements in medical treatments and vaccine delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
